The Form 4 filing, which reports an insider's stock activity, was filed on October 13, 2026. The sale took place four days earlier, on October 9. The filing identifies Laponis Adam as chief financial officer of Twist Bioscience Corp (TWST).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-09 |
| Date of Latest Transaction | 2026-10-09 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 2,462 |
| Price | $156.30 |
| Total Transaction Value | $384,822.66 |
| Insider | |
| Ticker Symbol | TWST |
| Company | Twist Bioscience Corp |
| Insider Name | Laponis Adam |
| Insider Title | Chief Financial Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 98,114 |
| Position Size Change | 2.45% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of shares, reported under transaction code S. One transaction was reported. The available details also point to a link with tax coverage or an exercise-price payment, explained below.
What was the average price of the transaction?
The average sale price was $156.30 per share when rounded to cents. The reported price before rounding was $156.3049 per share.
How did this transaction affect the insider's holdings?
Laponis Adam sold 2,462 shares and reported owning 98,114 shares afterward. The sale covered 2.45% of the shares owned before the trade. The reported balance shows shares remained after this sale.
What's the total transaction value?
The total value was $384,822.66 when rounded to cents. The unrounded value was $384,822.6638. This amount covers the one reported sale.
Are there any special circumstances around this transaction?
The available information points to tax coverage or payment of a stock option's exercise price. A stock option gives someone the right to buy shares at a set price. The exercise price is the amount paid to use that right.
The footnote text is unavailable here, so the exact purpose and payment method remain unknown. The information does not establish that taxes were the sole purpose of the sale.
For research purposes only; not investment advice.